Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,772
Total Claims
$850K
Drug Cost
359
Beneficiaries
$2,368
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+68%
Cost per patient vs peers
$2,368 vs $1,411 avg
+32%
Brand preference vs peers
14.1% vs 10.6% avg
Brand vs Generic
Brand: 1,784 claims · $652K
Generic: 10,883 claims · $195K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 119 | $85K |
| Empagliflozin | 66 | $71K |
| Sitagliptin Phos/Metformin Hcl | 37 | $48K |
| Levothyroxine Sodium | 701 | $45K |
| Insulin Glargine,hum.Rec.Anlog | 60 | $40K |
| Sitagliptin Phosphate | 35 | $29K |
| Rivaroxaban | 43 | $26K |
| Insulin Lispro Protamin/Lispro | 32 | $25K |
| Dapagliflozin Propanediol | 29 | $24K |
| Sitagliptin Phos/Metformin Hcl | 29 | $23K |
| Insulin Lispro | 29 | $14K |
| Insulin Nph Hum/Reg Insulin Hm | 31 | $14K |
| Linaclotide | 15 | $13K |
| Budesonide/Formoterol Fumarate | 33 | $13K |
| Tiotropium Br/Olodaterol Hcl | 20 | $9,637 |
Prescribing Profile
Patient Profile
76
Avg Age
72%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data